ONVO 1 (-2.91%)
US68620A2033Medical Diagnostics & ResearchDiagnostics & Research

Organovo Holdings (ONVO) Competitor Comparison

We are evaluating the key criteria listed to compare Organovo Holdings (ONVO) against its competitors in the Diagnostics & Research industry.

Linearity 10 years - ONVO ranking 38 / 58

These are the competitors of Organovo Holdings in the industry Diagnostics & Research ranked by linearity 10 years
1. Ortho Clinical Diagnostics Holdings OCDX
33.4
2. CareDx CDNA
25.99
3. Illumina ILMN
23.19
4. Neogen NEOG
14.83
5. Guardant Health GH
11.76
6. Sera Prognostics SERA
8.58
7. Inotiv NOTV
7.93
8. Pacific Biosciences of California PACB
7.6
9. Twist Bioscience TWST
6.4
10. Global Cord Blood CO
5.67
11. SeqLL SQL
5.36
12. DarioHealth DRIO
5.33
13. Olink Holding OLK
5.29
14. Fulgent Genetics FLGT
4.43
15. Myriad Genetics MYGN
3.72
16. Syneos Health SYNH
3.71
17. Sotera Health SHC
3.69
18. Enzo Biochem ENZ
3.54
19. Co-Diagnostics CODX
3.36
20. Qiagen QGEN
3.17
21. Anixa Biosciences ANIX
2.93
22. National Research NRC
2.88
23. Psychemedics PMD
2.79
24. NeoGenomics NEO
2.4
25. Bioventus BVS
2.32
26. Exagen XGN
2.21
27. Aspira Womens Health AWH
2.18
28. MDxHealth MDXH
2.17
29. Meridian Bioscience VIVO
2.1
30. Biodesix BDSX
2.06
31. MaxCyte MXCT
1.97
32. bioAffinity Technologies BIAF
1.95
33. Quest Diagnostics DGX
1.92
34. Prenetics Global PRE
1.92
35. Personalis PSNL
1.83
36. Neuronetics STIM
1.72
37. Laboratory Corp of America Holdings LH
1.69
38. Organovo Holdings ONVO
1.64
39. Trinity Biotech TRIB
1.57
40. Exact Sciences EXAS
1.46
41. Waters WAT
1.34
42. Interpace Biosciences IDXG
1.19
43. PerkinElmer PKI
1.15
44. Precipio PRPO
1.1
45. Charles River Laboratories CRL
0.9
46. Agilent Technologies A
0.83
47. Danaher DHR
0.72
48. Mettler-Toledo MTD
0.67
49. IQVIA Holdings IQV
0.58
50. Heska HSKA
0.52
51. Thermo Fisher Scientific TMO
0.49
52. Natera NTRA
0.46
53. IDEXX Laboratories IDXX
0.37
54. Lantheus Holdings LNTH
0.36
55. Medpace Holdings MEDP
0.31
56. RadNet RDNT
0.31
57. DexCom DXCM
0.28
58. Icon ICLR
0.25

Obligatory risk notice

We would like to point out that the contents of this website are for general information purposes only and do not constitute recommendations for the purchase or sale of specific financial instruments, and therefore do not constitute investment advice. In particular, marketstorylabs.com and its creators cannot assess the extent to which information / recommendations made on the pages correspond to your investment objectives, your risk tolerance and your ability to bear losses. Therefore, if you make any investment decisions based on information on the site, you do so solely on your own responsibility and at your own risk. This in turn means that neither marketstorylabs.com nor its creators are liable for any losses incurred as a result of investment decisions based on the information on the marketstorylabs.com website or other media used.